Why Veterans Are Turning to Hemp

There are more than 18 million veterans living in the United States right now. Between 11 and 20 percent of those who deployed to Iraq or Afghanistan have returned with post-traumatic stress disorder, according to the VA's National Center for PTSD. Many came home with chronic pain that did not leave when they did. And according to the VA's most recent National Veteran Suicide Prevention Annual Report, an average of 17.5 veterans die by suicide every single day.

This is not a peripheral problem. This is the central problem. And for many veterans, the pharmaceutical toolkit has not been enough.

Opioids for the pain. Benzodiazepines for the sleep. Antipsychotics for the nightmares. SSRIs for the depression that can follow the combination of all the above. The average veteran with PTSD is prescribed multiple medications simultaneously. The side effects of those medications can produce symptoms that require additional medications. The picture gets complicated fast.

For the better part of a decade, veterans have also been turning to hemp and cannabis. Often quietly, and often without much clinical guidance to go on. Many have reported finding something useful there. The research is starting to explain why.

The research is starting to catch up.

Why Veterans Use Hemp. The Real Reason.

The standard narrative is that veterans use cannabis to get high and avoid dealing with their problems. This narrative is wrong, and the people repeating it have not spent much time talking to veterans.

The actual reason is that the human body runs an internal signaling network called the endocannabinoid system. Every person has one. It regulates sleep, pain perception, emotional processing, memory consolidation, stress response, and appetite. It is one of the most fundamental regulatory systems in the body, and it operates using naturally occurring compounds called endocannabinoids that are chemically similar to the cannabinoids in hemp.

Combat and chronic trauma do something specific to this system. They dysregulate it.

Research published in Molecular Psychiatry by Dr. Alexander Neumeister at NYU School of Medicine documented that individuals with PTSD show significantly lower concentrations of anandamide, one of the primary endocannabinoids the body produces naturally, than people without PTSD. The study used brain imaging to confirm this, making it the first of its kind. Anandamide is sometimes called the "bliss molecule," which undersells its actual function. It is not a mood enhancer. It is a fear-extinction signal. When the endocannabinoid system functions normally, anandamide helps tell the brain that a past threat no longer requires a current response. In individuals with PTSD, that signal is diminished or absent.

This is why many veterans describe their PTSD not as sadness but as a hypervigilance that never turns off. The threat response is stuck open. The off switch is broken.

CBD and THCA interact with the endocannabinoid system through CB1 and CB2 receptors distributed throughout the brain and body. CBD in particular inhibits an enzyme called fatty acid amide hydrolase (FAAH), which is responsible for breaking down anandamide. When FAAH is inhibited, anandamide stays active longer. The fear-extinction signal gets a longer window to operate. This is not a sedative effect. It is a regulatory effect. There is a significant difference.

Chronic Pain, the Physical Reality Nobody Talks About Enough

PTSD gets the majority of the attention, and it deserves it. But the physical toll of military service is its own conversation, and it is not a short one.

Joint damage. Spinal injury. Traumatic brain injury. Nerve damage from blast exposure. Repetitive stress injuries from years of carrying load. By the time most combat veterans reach their 40s, their bodies have accumulated damage that would be exceptional in a civilian of the same age. The VA has managed this primarily with opioids and NSAIDs, which is how you end up with a veteran population disproportionately affected by opioid dependency.

Multiple published sources, including a statement by VA Secretary Robert Wilkie and research published in PMC journals, confirm that veterans experience opioid overdose deaths at roughly twice the rate of the general population. Veterans with PTSD are prescribed opioids at substantially higher rates than those without. The combination of opioid dependency and psychiatric medication is, by a significant margin, one of the most dangerous places a human body can be.

Hemp and cannabis offer a different interaction with pain. Two pathways are particularly relevant.

The first is the endocannabinoid pathway already described. CB1 receptors are distributed throughout pain-processing areas of the spinal cord and brain. When cannabinoids bind to those receptors, they modulate pain signaling through a system the body already uses.

The second is the terpene pathway. Caryophyllene, a terpene present in many hemp strains, is the only terpene that directly activates CB2 receptors. CB2 receptors are concentrated in immune and inflammatory tissue. When caryophyllene binds to CB2 receptors, it modulates the inflammatory response associated with chronic pain. This is an anti-inflammatory mechanism working through the body's own regulatory architecture.

Sleep. The One Nobody Gets Right.

Sleep disruption is not a side effect of PTSD. It is one of its defining features. Veterans with PTSD experience nightmares, hyperarousal during sleep cycles, difficulty initiating sleep, and fragmented rest that leaves them as exhausted in the morning as they were the night before. The standard pharmaceutical response is prazosin for nightmares, trazodone or benzodiazepines for initiation, and sleep studies to document what everyone already knew was happening.

CBN, the cannabinoid found in aged hemp and specifically formulated into sleep products, operates through sedative mechanisms that are distinct from benzodiazepines. Benzos suppress REM sleep. They reduce the restorative depth of the sleep cycle. Long-term benzo use produces rebound insomnia when discontinued that is frequently worse than the original problem. The dependency profile is severe.

CBN works through the endocannabinoid system to support sleep onset and maintenance without the same interaction with GABA receptors that produces benzo dependency. Research on CBN's specific sleep mechanism is still developing, but the existing data and the reported experience of users who have moved away from pharmaceutical sleep aids point in a consistent direction.

Delta 9 THC also affects the sleep cycle, specifically by suppressing REM. This is why high-potency THC can produce longer sleep duration without full restorative benefit. The implication for veterans using hemp for sleep is that a CBN-dominant formula with lower THC is likely more restorative than high-THC alone, a distinction that matters when someone has been running a sleep deficit for years.

The Research Gap and Why It Exists

VA providers currently cannot recommend cannabis. This is a federal policy rooted in the Schedule I classification of cannabis under the Controlled Substances Act, which defines the plant as having no accepted medical use and high abuse potential. That classification has been in place since 1970. The result is that providers who want to discuss a compound their patients are already using are constrained in what they can say. Veterans are largely left to navigate the product landscape on their own.

That constraint is worth understanding because it shapes everything downstream. It is not that clinicians lack interest or that patients lack need. It is that the regulatory framework has not kept pace with the research. Many veterans have described filling that gap themselves, which is how you end up with tens of thousands of people running an informal experiment without clinical support.

A 2023 study published in Clinical Therapeutics, drawing on survey data from 510 veterans, found that 91 percent of respondents reported that medical cannabis helped them experience a greater quality of life, and 21 percent reported using fewer opioids as a result of their cannabis use. These are self-reported outcomes, not a clinical trial. But they represent consistent signal from a large population, and they are the kind of numbers that serious researchers are now following up on.

What Veterans Should Actually Know Before They Start

If you are a veteran considering hemp or cannabis for any of the above, there are things the industry will not tell you that you deserve to know.

THCA is not CBD. THCA, when smoked or vaporized, converts to Delta 9 THC through a process called decarboxylation. It produces psychoactive effects. It will appear on a drug test. If you are subject to VA drug testing or any employment testing, hemp flower and THCA products carry real risk regardless of their federal legal status. CBD products made from broad-spectrum or isolate formulations do not carry the same risk, but even trace amounts of THC in full-spectrum products can accumulate and appear on a panel test. Know what you are using before you use it.

Dosing is not standardized. The hemp industry has no dosing protocol equivalent to pharmaceutical prescribing. Start with the lowest reasonable dose. Give it adequate time before increasing. The entourage effect means a full-spectrum product with terpenes will behave differently than an isolate. High-potency products used without experience can produce anxiety rather than reduce it, which is the opposite of what most veterans are seeking.

Terpene profile matters for PTSD specifically. Myrcene-dominant strains tend toward sedation and physical relaxation. Limonene-dominant strains tend toward mood elevation and mental clarity. For veterans whose primary symptom is hypervigilance and overactivation, a high-myrcene formula used in the evening may be more appropriate than a limonene-forward product that adds stimulation to an already overloaded nervous system. The compound picture matters more than the THC number.

Not all hemp products are the same. Lab testing is the only honest signal. A product with no COA (Certificate of Analysis) from a third-party lab is a product you cannot verify. The dosing may be inaccurate, the cannabinoid content may be misrepresented, and the terpene profile, if listed, may not reflect what is actually in the product. Every legitimate hemp brand provides COA documentation. If they do not, find one that does.

Hemp is not a substitute for clinical care. This requires saying clearly. If you are in crisis, if you are having thoughts of self-harm, if you are managing severe PTSD without professional support, hemp does not replace that support. It can be one tool in a larger approach. It should not be the only one. The Veterans Crisis Line is 988, then press 1.

Today is the day we remember the ones who did not come back. But the veterans who did come back are still here, still carrying the weight of what they were asked to do, still navigating a system that processes them more efficiently than it helps them.

The hemp plant is not a miracle. It is a compound-rich agricultural product that interacts with a fundamental regulatory system in the human body. The research on how it interacts with trauma, chronic pain, and sleep dysregulation is not complete. It is, however, substantial, consistent, and building. The veterans who have been exploring this without much formal guidance have been doing something worth taking seriously.

We should take them at their word.